vs
BXP, Inc.（BXP）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是BXP, Inc.的1.7倍（$1.5B vs $872.1M），BXP, Inc.净利率更高（15.3% vs 12.9%，领先2.4%），Steris同比增速更快（9.2% vs 0.8%），过去两年Steris的营收复合增速更高（15.8% vs 1.3%）
BXP是美国头部商业地产投资信托企业，核心业务为持有、运营及开发A级高端写字楼资产，项目覆盖纽约、波士顿、旧金山等美国核心都市圈，服务企业、科技、专业服务等领域的多元租户。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
BXP vs STE — 直观对比
营收规模更大
STE
是对方的1.7倍
$872.1M
营收增速更快
STE
高出8.4%
0.8%
净利率更高
BXP
高出2.4%
12.9%
两年增速更快
STE
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $872.1M | $1.5B |
| 净利润 | $133.0M | $192.9M |
| 毛利率 | — | 43.8% |
| 营业利润率 | — | 18.3% |
| 净利率 | 15.3% | 12.9% |
| 营收同比 | 0.8% | 9.2% |
| 净利润同比 | 53.0% | 11.2% |
| 每股收益（稀释后） | $1.69 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BXPSTE
| Q1 26 | $872.1M | — | ||
| Q4 25 | $877.1M | $1.5B | ||
| Q3 25 | $871.5M | $1.5B | ||
| Q2 25 | $868.5M | $1.4B | ||
| Q1 25 | $865.2M | $1.5B | ||
| Q4 24 | $858.6M | $1.4B | ||
| Q3 24 | $859.2M | $1.3B | ||
| Q2 24 | $850.5M | $1.3B |
净利润BXPSTE
| Q1 26 | $133.0M | — | ||
| Q4 25 | $248.4M | $192.9M | ||
| Q3 25 | $-121.7M | $191.9M | ||
| Q2 25 | $89.0M | $177.4M | ||
| Q1 25 | $61.2M | $145.7M | ||
| Q4 24 | $-228.9M | $173.5M | ||
| Q3 24 | $83.6M | $150.0M | ||
| Q2 24 | $79.6M | $145.4M |
毛利率BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | 58.8% | 43.8% | ||
| Q3 25 | 59.3% | 44.2% | ||
| Q2 25 | 59.2% | 45.1% | ||
| Q1 25 | 59.2% | 43.3% | ||
| Q4 24 | 59.7% | 44.5% | ||
| Q3 24 | 59.5% | 43.6% | ||
| Q2 24 | 59.8% | 44.7% |
营业利润率BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | — | 18.3% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 17.7% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 17.9% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | — | 14.5% |
净利率BXPSTE
| Q1 26 | 15.3% | — | ||
| Q4 25 | 28.3% | 12.9% | ||
| Q3 25 | -14.0% | 13.1% | ||
| Q2 25 | 10.2% | 12.8% | ||
| Q1 25 | 7.1% | 9.8% | ||
| Q4 24 | -26.7% | 12.7% | ||
| Q3 24 | 9.7% | 11.3% | ||
| Q2 24 | 9.4% | 11.4% |
每股收益（稀释后）BXPSTE
| Q1 26 | $1.69 | — | ||
| Q4 25 | $1.56 | $1.96 | ||
| Q3 25 | $-0.77 | $1.94 | ||
| Q2 25 | $0.56 | $1.79 | ||
| Q1 25 | $0.39 | $1.48 | ||
| Q4 24 | $-1.46 | $1.75 | ||
| Q3 24 | $0.53 | $1.51 | ||
| Q2 24 | $0.51 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $512.8M | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $7.7B | $7.2B |
| 总资产 | $25.1B | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资BXPSTE
| Q1 26 | $512.8M | — | ||
| Q4 25 | $1.5B | $423.7M | ||
| Q3 25 | $861.1M | $319.2M | ||
| Q2 25 | $447.0M | $279.7M | ||
| Q1 25 | $398.1M | $171.7M | ||
| Q4 24 | $1.3B | $155.2M | ||
| Q3 24 | $1.4B | $172.2M | ||
| Q2 24 | $685.4M | $198.3M |
总债务BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B |
股东权益BXPSTE
| Q1 26 | $7.7B | — | ||
| Q4 25 | $5.1B | $7.2B | ||
| Q3 25 | $5.0B | $7.0B | ||
| Q2 25 | $5.3B | $7.0B | ||
| Q1 25 | $5.3B | $6.6B | ||
| Q4 24 | $5.4B | $6.4B | ||
| Q3 24 | $5.8B | $6.6B | ||
| Q2 24 | $5.8B | $6.4B |
总资产BXPSTE
| Q1 26 | $25.1B | — | ||
| Q4 25 | $26.2B | $10.6B | ||
| Q3 25 | $26.0B | $10.4B | ||
| Q2 25 | $25.6B | $10.4B | ||
| Q1 25 | $25.4B | $10.1B | ||
| Q4 24 | $26.1B | $10.0B | ||
| Q3 24 | $26.4B | $10.2B | ||
| Q2 24 | $25.5B | $10.1B |
负债/权益比BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $298.2M |
| 自由现金流经营现金流 - 资本支出 | — | $199.5M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | 1.5% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | $407.8M | $298.2M | ||
| Q3 25 | $274.2M | $287.8M | ||
| Q2 25 | $353.1M | $420.0M | ||
| Q1 25 | $210.0M | $260.8M | ||
| Q4 24 | $383.7M | $332.8M | ||
| Q3 24 | $286.1M | $250.7M | ||
| Q2 24 | $367.1M | $303.7M |
自由现金流BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | $362.7M | $199.5M | ||
| Q3 25 | $231.6M | $201.3M | ||
| Q2 25 | $281.5M | $326.4M | ||
| Q1 25 | $152.6M | $189.9M | ||
| Q4 24 | $312.5M | $243.6M | ||
| Q3 24 | $234.5M | $148.8M | ||
| Q2 24 | $332.4M | $195.7M |
自由现金流率BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | 41.4% | 13.3% | ||
| Q3 25 | 26.6% | 13.8% | ||
| Q2 25 | 32.4% | 23.5% | ||
| Q1 25 | 17.6% | 12.8% | ||
| Q4 24 | 36.4% | 17.8% | ||
| Q3 24 | 27.3% | 11.2% | ||
| Q2 24 | 39.1% | 15.3% |
资本支出强度BXPSTE
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.1% | 6.6% | ||
| Q3 25 | 4.9% | 5.9% | ||
| Q2 25 | 8.2% | 6.7% | ||
| Q1 25 | 6.6% | 4.8% | ||
| Q4 24 | 8.3% | 6.5% | ||
| Q3 24 | 6.0% | 7.7% | ||
| Q2 24 | 4.1% | 8.4% |
现金转化率BXPSTE
| Q1 26 | — | — | ||
| Q4 25 | 1.64× | 1.55× | ||
| Q3 25 | — | 1.50× | ||
| Q2 25 | 3.97× | 2.37× | ||
| Q1 25 | 3.43× | 1.79× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | 3.42× | 1.67× | ||
| Q2 24 | 4.61× | 2.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
